This was the stock's third consecutive day of gains.
Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade ...
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a ...
11h
Hosted on MSNGreenwich Academy's 2025 commencement speaker is the CEO of animal health company ZoetisGreenwich Academy's 2025 commencement speaker is alumna Kristin Coveny Peck, the CEO of animal health company Zoetis. Peck graduated from Greenwich Academy in 1989. She became the company's CEO in ...
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results